Parmax Pharma Ltd (BSE: 540359) is a Rajkot, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹95 Cr, it ranks #3,318 by market cap among the 6,137 Indian listed companies on FinBizNet, and #71 of 86 in Medicinal Chemicals and Botanical Products. At ₹136.40 (as of 25 Oct 2026), the share price is 1.9% below its 52-week high of ₹139.10 and 440.8% above its 52-week low of ₹25.22. The share price is up 295.4% over one year and up 32.6% over three months.
| Current Price | ₹136.40 |
|---|---|
| Market Cap | ₹95 Cr |
| BSE Code | 540359 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| 52-Week Range | ₹25.22 – ₹139.10 |
| 1-Year Price Change | +295.4% |
| 3-Month Price Change | +32.6% |
| Beta (1Y) | 0.21 |
| Headquarters | Rajkot, Gujarat |
| Website | www.parmaxpharma.com |
Parmax Pharma Limited operates in the pharmaceutical business in India. It manufactures and sells bulk drugs, drug intermediates, and specialty chemicals. The company was incorporated in 1994 and is based in Rajkot, India.
1. 0-0
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Parmax Pharma Ltd | ₹95 Cr | — | — | — | +295.4% |
Listed by market capitalisation. Ratios are shown for context only.
Parmax Pharma Ltd is trading at ₹136.40, with a market capitalisation of ₹95 Cr.
Parmax Pharma Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Parmax Pharma Ltd is listed on the BSE under the scrip code 540359.
Parmax Pharma Ltd's share price is up 295.4% over one year and up 32.6% over three months. Its 52-week range is ₹25.22 to ₹139.10.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.